Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial.

Journal of immunotherapy (Hagerstown, Md. : 1997) - 1 Jan 2000

Lee Wei-Chen, Wang Hui-Chuan, Hung Chien-Fu, Huang Pei-Fang, Lia Chen-Rong, Chen Miin-Fu

Abstract excerpt

Hepatocellular carcinoma (HCC) is a common and rapidly progressing malignancy. Current treatment options for advanced HCC are limited. This clinical study of dendritic cell (DC)-based immunotherapy for HCC enrolled 31 patients with advanced HCC. DCs, propagated from peripheral blood monocytes, were pulsed with autologous tumor lysates to treat HCC. The first 14 patients underwent pulsed therapy with five courses...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Vaccines
Share to Dendritic Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypersensitivity, Delayed

Share to Immunotherapy

Share to Immunotherapy, Adoptive

Share to Lymphocytes

Share to Monocytes

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 16113606
DOI: 10.1097/01.cji.0000171291.72039.e2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial.PMID 16113606Read ↗

A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer.Semantic proximity Read ↗

Dendritic cells pulsed with alpha-fetoprotein and mutant P53 fused gene induce bi-targeted cytotoxic T lymphocyte response against hepatic carcinoma.Semantic proximity Read ↗

Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma.Semantic proximity Read ↗

Induction of human tumor-loaded dendritic cells.Semantic proximity Read ↗

Administration of dendritic cells in cancer nodules in hepatocellular carcinoma.Semantic proximity Read ↗

CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.Semantic proximity Read ↗

Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cells.Semantic proximity Read ↗

In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells.Semantic proximity Read ↗

Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells.Semantic proximity Read ↗

Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells.Semantic proximity Read ↗

Apoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart.Semantic proximity Read ↗

Human monocyte-derived dendritic cells pulsed with wild-type p53 protein efficiently induce CTLs against p53 overexpressing human cancer cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.